YORBA LINDA, CA (PRWEB)
February 17, 2022

Laboratoryleading science social networking website offering top-notch interactive virtual events and webinars, hosts its Drug discovery and development annual virtual event on February 23, 2022 bringing together leading academics and innovative industry experts, clinicians, laboratory managers, scientists and medical professions from around the world. Marking the 5th year, the symposium features another exciting line-up of distinguished guests speakers covering key topics and sharing new findings and advances with the scientific community.

The one-day event features two keynote speakers: Professor Kevin Pfleger, MA, PhD, Director of Biomedical Innovation, University of Western Australia, explaining how bioluminescent resonance energy transfer technology (BRET ) can be used to monitor receptor complexes, and Dr. Michelle Longmire, CEO and co-founder of Medable, presenting a keynote entitled “Engineering the Quantum Leap that Drug Development Needs”, examining technologies and processes to provide clinical trials more reactive and streamlined solutions and the main obstacles to faster drug development.

“The ability to monitor ligand-receptor and protein-protein interactions in live cells and in real time has transformed our ability to assess the intricacies of molecular pharmacology,” according to Professor Kevin Pfleger from the University of Western Australia. . “Bioluminescence Resonance Energy Transfer (BRET) has played a central role in this transformation, particularly with regard to the study of G protein-coupled receptors, and during my presentation I will introduce the public to the contribution from my laboratory to its development and application.

Drug Discovery & Development 2022 promises to deliver a agenda including sessions ranged from new approaches to drug discovery and preclinical development, to explorations of PK/PD and pharmacogenomics, and finally an overview of clinical development progress. Kicking off the afternoon discussions is a panel presentation titled “Digital Solutions to Mitigate the Challenges of NASH Clinical Trials” presented by Dr. Paul McCracken, Debbie Marshall and Christina Gonzales, of ICON, exploring the NASH clinical trial challenges and how digital technologies provide high-quality, non-invasive solutions for NASH clinical trial enrollment.

This premier event highlights more than 15 all-day presentations, including other topics such as autoantibodies as biomarkers in immuno-oncology, standardized and reproducible solutions for cytometry analysis in flow, innovative approaches to biomarker discovery in the drug development process, enabling translation of biomarker research to clinical practice, identification of the ideal in vitro model for various research applications and personalized medicine through GPCR pharmacogenomics, to name a few.

“Now in its 5th year, we are proud to provide a unique and highly valuable platform to inspire cross-disciplinary exchange at the cutting edge of drug discovery, a rapidly evolving field, through our Drug Discovery & Development virtual event,” said Greg Cruikshank, Chief Executive Officer of Labroots. “In kicking off 2022 with this first event, we continue to strive to produce such critical educational resources and content, and more networking opportunities between researchers, industry and academic institutions and others. members of the scientific community who are poised to impact the field for years to come.”

Produced on Labroots’ robust platform, while seamlessly connecting to all desktop and mobile devices, the interactive environment includes a lobby equipped with leaderboard and gamification, an auditorium with video webcasts live, a display room to explore data and engage in live chat conversations, Exhibit Hall (stimulating innovations and highlighting recent contributions to the field) and a networking lounge to encourage collaborations with a social media wall and a photo booth – all to provide an enriched learning experience for attendees.

By participating and attending this event, one continuing education credit (1 per presentation) can be earned for a maximum of 30 credits. To register for the event, click here. Use #LRdrug to follow the conversation online!

About Labroots

Labroots is the leading science social networking website and leading source for science news and leading virtual events and educational webinars and more. Advancing science through content sharing capabilities, Labroots is a powerful advocate for amplifying global networks and communities. Founded in 2008, Labroots focuses on digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay at the top of their field by earning continuing education credits on a wide range of topics through their participation in webinars and virtual events.

Share the article on social networks or by e-mail: